Twitter LinkedIn
    Tuesday, August 9
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Investments»Hutchison China MediTech secured $100M equity investment by Baring Private Equity Asia
    Investments

    Hutchison China MediTech secured $100M equity investment by Baring Private Equity Asia

    April 8, 20211 Min Read
    LinkedIn Facebook Twitter Email WhatsApp
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    Hutchison China MediTech Limited, has issued $100M of shares at $30.5 per American Depositary Share via a private placement to funds affiliated with Baring Private Equity Asia (BPEA). Each ADS represents five shares

    Proceeds will fund ongoing research and clinical development and support the further growth of commercialization capabilities both in China and globally.
    Mr. Christian Hogg, Chief Executive Officer of HUTCHMED, said, “We expect significant growth of our business this year as we look to accelerate our oncology revenues from ELUNATE, SULANDA and the potential upcoming approval of savolitinib, likely to be a first-in-class selective c-MET inhibitor in China.

    We are rapidly expanding global development of our ten oncology assets, all of which were discovered in-house at HUTCHMED, and are planning to initiate 8-10 registration and registration-intent studies in 2021. This is the right time to welcome BPEA to our existing shareholder base, a firm with a long history of supporting innovative globally-focused businesses. We look forward to partnering with BPEA in the next stage of our development.”

    Read more

    Source: Seeking Alpha

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    Capital deals and transactions Fundraising Investments
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    New Warburg Pincus investment values MRL at $2.25B

    August 8, 2022

    Carlyle to acquire controlling stake in Ocmis

    August 8, 2022

    BlackRock to offer Crypto for Institutional Investors through Coinbase

    August 8, 2022

    Abris-backed GreenGroup buys UAB Ecso

    August 8, 2022

    Comments are closed.

    Other Articles

    Prestige to rebuild office portfolio in the next 5-7 years after Blackstone selloff deal

    January 12, 2021

    Inter President Steven Zhang In Talks With Bain Capital Regarding €250M Bridge Loan

    February 21, 2021

    Kian Capital Partners Completes Exit of Westcoast Gate to Aurora Capital Partners

    November 22, 2021

    Carlyle preferred bidder for Baring PE’s Hexaware in $3 bln deal, sources say

    August 30, 2021

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2022 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?